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Abstract
Background: Neonatal sepsis causes 0.5 million deaths annually, mostly in low resource settings. Babies born in
African rural homes without running water or toilet facilities are especially vulnerable. Alcohol-based hand rub
(ABHR) may be used by mothers and carers as an alternative to hand washing with soap to prevent neonatal
infection. However, no definite study has established the preferred formulation of hand rub for the mothers. This
study aimed to assess the effects of addition of bitterants and perfume towards the acceptability of the alcohol-
based hand rubs by the mothers in their homes after childbirth.
Methods: This was a 3-way blinded cross-over study design. Mothers with children aged ≤3 months were recruited
from immunisation clinics at 3 local health facilities in rural eastern Uganda and received 3-different ABHR formulations
(in the order plain, bitterant and perfumed) packed in 100 ml bottles. Each ABHR was used for 5 consecutive days
followed by a 2-day ‘washout’ period (evaluation period). Overall satisfaction with each hand rub was evaluated at the
end of each week using a 7-point Likert scale.
Results: A total of 43 women were recruited, whose ages ranged from 16 to 45 years (mean 26.2 years old). None of
the participants normally used a hand protective lotion/cream. The three formulations were used for a mean of 5
(range 3–7) days. A significantly greater volume of the “bitterant” and “perfumed” formulations (mean 91 and 83 ml
respectively) were used in comparison to the “plain” formulation (mean 64 ml). Overall satisfaction was high with all
the hand rubs, but the perfumed formulation had a significantly higher overall satisfaction score [mean 6.7, range 4–7]
compared with the plain [6.4, 3–7] and bitterant [6.2, 2–7] formulations.
Conclusions: All the 3 ABHR formulations were well accepted with little to choose between them. The ABHR with
added perfume scored highest on overall satisfaction and was used significantly more often than plain ABHR. ABHR
with bitterant additive did, however, score highly and may be a preferable choice to those with concern over alcohol
misuse.
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Background
More than 3 million neonatal deaths occur annually
across the globe [1]. This accounts for two-fifths of the
7.6 million under-5-year-olds who died in 2010, with
these deaths almost exclusively in low-income countries
[1–3]. Neonatal sepsis results in half a million deaths
each year. African community studies suggest 42% of
neonatal deaths are due to infections [4].
In Uganda, with over 1.5 million live births annually,
142,000 die every year and 33% of these deaths occur in
the neonatal period (0–28 days of life) [5]. Uganda ranks
in the 10 highest neonatal mortality countries globally. In
Uganda, the majority of newborn infections and deaths
occur in the community, outside a health facility setting
and are frequently unreported to the health sector [6].
Evidence shows that these infant infections are dis-
eases of poverty, associated with poor home environ-
ments, remoteness, hunger, undernutrition, and lack of
access to essential services [7–9]. Whilst some patho-
gens are transmitted directly, most are transmitted from
toilets, animals, gardens or other unclean areas through
carers’ hands [10].
Hand washing with soap at the household level is
recommended as an important hand hygiene measure to
prevent transmission of such infections [10, 11] but this
is not so easy when there is no tap water nearby, or
when the water itself is dirty or scarce. Alcohol-based
hand rub (ABHR) may be used by mothers and carers as
the alternative, to prevent the spread of infection to the
infants. A large study comparing maternal ABHR use
with normal care for prevention of newborn infective
morbidity in villages around Mbale, eastern Uganda is
planned. As yet, no study has established the optimal
formulation of hand rub for the mothers. In European
hospital settings, ABHR commonly contains bitterant to
prevent its oral ingestion by alcoholics, people with
alcohol-use disorders, children and mentally ill older
people. This is also common in communities where al-
cohol ingestion is prohibited. However, this use of bitter-
ant could affect the taste of food when hands are used
for eating, as in Mbale district. An alternative would be
to add perfume to the ABHR. This would increase its
acceptability as well as deterring oral ingestion.
This study aimed to assess the effects of addition of bit-
terants and perfume on the acceptability of the
alcohol-based hand rubs by the mothers in their homes
following childbirth. In this study, we were interested in
establishing the preferred ABHR formulation, which later
could be used in a cluster randomised trial with an out-
come of sepsis amongst newborns in the first 3 months
after birth. In this study, women with newborns up to
3 months were included to establish inclusive experience
on the tolerability and acceptability of different ABHRs
for use in the future planned randomised controlled trial.
Methods
Setting
The study was carried out in Mbale district, Eastern
Uganda. The district has 46 government-run health
centres and one regional referral hospital. Mbale district
has an estimated population of 568,192 people in 912
villages and a network of 2454 trained Village Health
Workers as recorded from the district health office.
The alcohol-based hand rub (ABHR)
The formulations of ABHR were manufactured for the
study by Saraya East Africa Co. Ltd. based in Jinja,
Uganda. At the beginning of each week, participants
were given a 100 ml bottle of hand rub formulation with
a label containing usage and safety instructions and the
blinded formulation code (either A, B, or C). The codes
were added to enable the research team to confirm the
nature of the ABHR at the end of each follow-up period.
The bottle contents were stated as being an ABHR, but
it was not stated which additives were used. The follow-
ing formulations were compared: “A” was plain ABHR
containing ethanol 80% (Alsoft V, Saraya East Africa
Ltd); “B” was Alsoft V with added bittering agent, and
“C” was Alsoft V with an added floral perfume.
Recruitment
All women with children aged utmost 3 months attending
infant immunisation clinics in three lower health facilities
in Mbale district, eastern Uganda during the week
commencing 2nd June 2015 were screened for eligibility.
All women were included except those who were
currently using antiseptic hand wash at home and wished
to continue its use.
Design
This was a 3-way blinded non-randomised cross-over
study design. Each participant received the ABHRs in
the order “A” (plain), “B” (bitterant), “C” (perfumed of
floral scent). All three formulations were provided in
identical 100 ml bottles and colour with instructions to
use for 5 consecutive days, followed by a 2-day ‘washout’
period in which any or no hand rub could be used. Par-
ticipants were asked to return to the health centre with
their current ABHR bottle at the end of each week; the
research assistant then completed the study evaluation
from the participant’s perspective (participant’s reported
practice) and provided observer evaluation of the partici-
pant in line with the WHO protocol [12]. Hand rub
bottles from the previous week were retrieved and partici-
pants received the next ABHR formulation at each evalu-
ation visit. The frequency of ABHR use was assessed, the
amount of the formulation remaining in the bottle mea-
sured and any remaining hand rub was given back to
women only after the third formulation-follow up had
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been completed. The volume of ABHR consumed was
physically calculated by subtracting the remaining volume
of ABHR in the bottle at the time of evaluation from the
total volume in the bottle at the start (100mls). Those who
failed to attend for follow-up were contacted by mobile
phone or through the village health worker and the visit
was rescheduled to another appropriate time and place,
including the option of a home visit if preferred.
Participants were instructed by the researchers at the
time of recruitment on how to use the hand rubs based
on the adopted ‘3 moments of hand hygiene for commu-
nity neonatal care’ (Fig. 1) derived from the WHO ‘5 mo-
ments for hand hygiene’ in non-hospital settings [10]. The
three moments included; 1- before touching the baby (eg
before breastfeeding), 2- before a clean/aseptic procedure
(eg cleaning of the umbilical cord end until it falls off ),
3- after body fluid exposure (eg after using the toilet, after
cleaning baby’s bottom, after changing the baby’s diapers/
nappy). The moments’ poster was translated into the local
language (Lumasaba). Pictorial instructions on how to
hand rub were provided to each participant.
Data collection
Data were collected using the WHO validated tool
designed to evaluate the acceptability and tolerability of
different ABHRs [12]. The primary outcome measure
was the participant’s overall evaluation of the three
ABHRs on a 7-point Likert scale, demonstrated to
participants using water filling levels in a glass model for
each point scale, as shown in Fig. 2. At each evaluation
visit, a participant was asked to provide an overall evalu-
ation following the ABHR use according to the WHO
protocol [12]. Data were also collected on some partici-
pant demographics, the frequency of ABHR use, ABHR
volume consumed, the opinion of the hand rubs (colour,
smell, texture, ease of use, drying), skin condition after
use, and factors the participants both liked and disliked
about the ABHR. The frequency of ABHR Use was
assessed by asking women the number of times the hand
rub was used at the last 10 times that they did particular
activities related to the baby, like breastfeeding, changing
diapers, after using toilets etc.
The data were collected on paper case report forms
and then transferred onto a secure, password-protected
database for statistical analysis.
Sample size
A sample size of 40 mothers or carers with children ut-
most 3 months old and attending the immunisation clinics
was used. WHO protocol recommends approximately 40
volunteer participants using at least 30 ml of product per
day to participate in acceptability and tolerability studies
for ABHR use [12] and previous studies have adopted
similar sample size [13].
Statistical analysis
Participant characteristics and product performance mea-
sures were summarised using means and standard devia-
tions (± range) for continuous variables and frequency
counts (with percentages) for categorical measures. User
Fig. 1 The ‘3 Moments for community neonatal hand hygiene’ poster developed for BabyGel study. This shows an illustrative and diagrammatic
representation of the key moments of hand hygiene for newborns in the community
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comparisons of the performances of the three hand rub
formulations were summarised using mean differences
with their 95% confidence intervals. Observer evaluations
of the impact of the formulations on participants’ skin
condition were summarised using frequency counts and
percentages; as only one participant reported a (very
minor) problem, no formal statistical comparisons were
performed for these variables. Time spent away from
home compound by participants was measured using an
ordered categorical scale and summarised using frequency
counts with their percentages. Differences between the
formulations on this measure were evaluated using the
Wilcoxon matched-pairs rank sum test but mean scores
were also computed to help inform the interpretation of
these differences. Preferences for the two bottle sizes
(1-Litre large and 100 ml small) used were summarised
using frequency counts with their percentages; differences
between these preferences were evaluated using the
McNemar test. All analyses were conducted using the
SPSS 22.0 (IBM Corp, Chicago, USA). Statistical signifi-
cance was set at the conventional 5% level.
Results
Participants’ characteristics
Table 1 shows that a total of 43 women with children aged
utmost 3 months were recruited into this study from the
immunisation clinics at three lower health centres (HC)
(One HC4 facility at the county level and two HC3 facil-
ities at sub-county level) in rural eastern Uganda. Figure 3
shows the flow of participants in the study.
Every participant received each of the formulations over
three consecutive 7-day periods (3 weeks), in the order
‘plain’, ‘bitterant’, ‘perfumed’. The study was conducted
between 2nd and 16th June 2015, which was categorised
as the “humid” season. The mean age of the participants
was 26.2 years (range 16 to 45 years). Just over half of the
women (22; 51.2%) were classified as having “dark brown”
skin, almost one third (14; 32.6%) as having “black” skin,
and the remainder (7; 16.3%) as having “brown” skin.
None of the participants normally used a hand lotion/
cream. A small number of women indicated experiencing
conditions compatible with irritative or atopic dermatitis,
rhinitis, or allergic conjunctivitis and or asthma. No woman
reported an intolerance to alcohol. Just one woman consid-
ered that the ABHR could improve her own hand hygiene.
Evaluation of formulations by participants
Table 2 shows that all the three formulations were used
for an average of 5 (range 3–7) of the 7 evaluation days.
There was a gradual increase in the volume used over
time, with more amount for the perfumed and bitterant
formulations (mean 83 ml and 91 ml respectively) than
for the plain formulation (mean 64 ml). All women re-
ported that the three formulations had changed their
hand hygiene practices. The bitterant and perfumed for-
mulations were used more frequently than the plain for-
mulation for all activities assessed, with the single
exception of changing the baby’s nappy/diaper. However,
no statistically significant differences were observed be-
tween the bitterant and perfumed formulations for any
of the activities. Overall, all the ABHRs formulations
were well accepted by women but the ABHR with per-
fume additive was favoured, mean score 6.7 (range 4–7)
more than the plain ABHR, mean 6.4 (range 3–7) and
ABHR with the bitterant additive, mean 6.2 (range 2–7).
The preference was assessed based on colour, smell, tex-
ture, irritation, drying effect, ease of use, the speed of
drying and application of the ABHR formulation for
hand hygiene (Table 2).
The women reported that they left their home com-
pound when using the different formulations, but the
differences between the three formulations on this
item were small and probably not of any clinical rele-
vance. This finding might help the mother in plan-
ning for the amount of ABHR needed outside the
home, applying the ABHR to opportunities for hand
hygiene outside homes which would ultimately im-
prove adherence and acceptability beyond homes.
Fig. 2 The Glass model for Likert scale evaluation of the opinion of Carers/ mothers after use of the test product. The glass models were labelled
from 1 to 7 consistent with the filling levels and each participant was asked to indicate where she felt it is the best option for her following use
of the product
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Three-quarters of the women reported a preference
for the large (1 l) bottle rather than the small
(100 ml) bottle for all three formulations.
Observer evaluation of the test products
Table 3 shows that skin condition was rated as normal
for all women for all categories (redness, scaliness,
Table 1 Participant characteristics
Characteristic
Sample size 43
Date of enrolment range 2/6/15: 5/6/15
Age (years) mean (s.d.) [range] 26.2 (7.1) [16: 45]
Skin brown n (%) 7 (16.3)
dark brown n (%) 22 (51.2)
black n (%) 14 (32.6)
Present season humid n (%) 43 (100)
Do you normally use a protective hand lotion /cream
(outside test period)?
never n (%) 43 (100)
Do you develop irritative dermatitis? never n (%) 35 (81.4)
sometimes n (%) 7 (16.3)
always n (%) 1 (2.3)
Do you develop atopic dermatitis? yes n (%) 2 (4.7)
no n (%) 41 (95.3)
Do you develop rhinitis / allergic conjunctivitis? yes n (%) 3 (7.0)
no n (%) 40 (93.0)
Are you asthmatic? yes n (%) 1 (2.3)
no n (%) 42 (97.7)
Do you have a known intolerance to alcohol? no n (%) 43 (100)
Do you think you can improve your own hand
hygiene?
yes n (%) 42 (97.7)
perhaps n (%) 1 (2.3)
Did any of the following problems make it difficult
to use the hand rub (1 = always; 7 = never)?
Forgetfulness 1 (always) n (%) 0
2 n (%) 3 (7.0)
3 n (%) 4 (9.3)
4 n (%) 3 (7.0)
5 n (%) 1 (2.3)
6 n (%) 3 (7.0)
7 (never) n (%) 29 (67.4)
mean (s.d.) 6.0 (1.7)
Lack of time 1 (always) n (%) 0
2 n (%) 2 (4.7)
3 n (%) 0
4 n (%) 1 (2.3)
5 n (%) 1 (2.3)
6 n (%) 4 (9.3)
7 (never) n (%) 35 (81.4)
mean (s.d.) 6.6 (1.2)
Damaged skin 7 (never) n (%) 43 (100)
mean (s.d.) 7.0 (0)
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fissures and skin scale) both before and after the use of
all three formulations.
Discussion
In general, the differences between the ratings of the
three formulations were small, but the bitterant and per-
fumed formulations were preferred over the plain for-
mulation. The perfumed formulation scored significantly
higher than both the plain and bitterant varieties in the
overall evaluation. It also emerged as slightly better than
the bitterant formulation in terms of smell, with women
favouring the smell of the perfumed formulation more
than that of the bitterant and plain formulations. The
progressive increase in the volume of ABHR use over
time could be explained either by the preference of a
particular type of ABHR formulation or habit formation
over time which could have increased familiarity with
the product. Hence, we proposed the ABHR to be intro-
duced in the late weeks of pregnancy for mothers’ habit
formation and familiarity in the planned trial and future
use. In this study, there was no reported change in skin
colour after using the ABHR. The skin colour change
might be important in mainly brown or light-skinned
population to guide the participants and observers in the
occurrence of inflammatory reaction associated with the
ABHR [13]. However, it didn’t prove useful in this
African population.
To our knowledge, this is the first study to directly
compare preferences of the different formulations in a
blinded fashion in this setting. The results suggest that
the perfumed ABHR is favoured in these communities.
In clinical settings, formulations containing bitterant are
often preferred due to safety concerns about intentional
ingestion of the ABHR by people with alcohol misuse
disorder [14, 15]. The WHO recommends that in cases
where the risk of ingestion is very high (e.g. in paediatric
or confused patient situations), bitterants could be added
to make ABHRs unpalatable. At the outset, the study
team had concerns that the regular use of an ABHR
containing a bitterant could adversely affect the taste of
food in populations where food is consumed with the
hands. We found no evidence of this however from the
extra notes and it is likely that the ritualistic pre-meal
handwashing that is very socially important in Uganda
prevents any bitterant transferring to the food.
Discussions on likely unacceptability of ABHRs on
grounds of religion are widely debated [16] and it has
been argued that Muslim health workers might find
them difficult to use as contact with alcohol is religiously
forbidden [17, 18]. The consensus, however, is that there
is no skin absorption to cause concern on these grounds
[19]. In the setting where we conducted this study, 15%
of the population are Muslim. None of our participants
expressed any concerns about the hand rub in relation
to their religion from the extra notes taken.
Fig. 3 Participants flow in the study. This shows the potential participants screened and those recruited and the allocation to the ABHR formulations
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Acceptability was high and the participants expressed
their willingness to use the hand rubs at the time of the
research and in the future. In 2015, a study exploring
the same question amongst Swiss healthcare workers
also reported high acceptance rates [13].
The study is limited by the non-randomized order of
ABHR formulation use as described earlier. The
non-random nature doesn’t give an explanation for the
increasing volumes of ABHR use as a result of habit for-
mation. Further, alongside the observer evaluation,
which was objective, we had the self-reported evaluation
of the tolerability and acceptability of ABHR use from
participants and might have led to respondent’s bias. For
example, the volume of the ABHR use was entirely reli-
ant on the honesty of the participants. We assumed that
participants used the ABHR correctly instead of pouring
it or using it for other purposes.
Conclusion
We, therefore, report that ABHRs were well accepted
and could be used in interventions to improve hand hy-
giene in rural home settings in Uganda, with a prefer-
ence for a perfumed or bitterant additive. In view of the
potential for misuse, the formulation with bitterant was
selected for community use in the planned randomised
controlled trial. We recommend the early introduction
of ABHR to mothers before delivery for habit formation
and familiarity with the ABHR.
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